Have any questions? 706-721-6582 or cts@augusta.edu
This study compares two medications, ponatinib and imatinib, to see which works better in people who have been newly diagnosed with the disease called Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).